| Literature DB >> 33365035 |
Reetika Malik Yadav1, Maya Gupta1, Aparna Dalvi1, Umair Ahmed Bargir1, Gouri Hule1, Snehal Shabrish1, Jahnavi Aluri1, Manasi Kulkarni1, Priyanka Kambli1, Ramya Uppuluri2, Suresh Seshadri3, Sujatha Jagadeesh3, Beena Suresh3, Jayarekha Raja3, Prasad Taur4, Sivasankar Malaischamy5, Priyanka Ghosh5, Shweta Mahalingam5, Priya Kadam5, Harsha Prasada Lashkari6, Parag Tamhankar7, Vasundhara Tamhankar7, Shilpa Mithbawkar7, Sagar Bhattad8, Prerna Jhawar9, Adinarayan Makam10, Vandana Bansal11, Malathi Prasad12, Geeta Govindaraj13, Beena Guhan13, Karthik Bharadwaj Tallapaka14, Mukesh Desai4, Revathi Raj2, Manisha Rajan Madkaikar1.
Abstract
Prenatal Diagnosis (PND) forms an important part of primary preventive management for families having a child affected with primary immunodeficiency. Although individually sparse, collectively this group of genetic disorders represents a significant burden of disease. This paper discusses the prenatal services available for affected families at various centers across the country and the challenges and ethical considerations associated with genetic counseling. Mutation detection in the index case and analysis of chorionic villous sampling or amniocentesis remain the preferred procedures for PND and phenotypic analysis of cordocentesis sample is reserved for families with well-characterized index case seeking PND in the latter part of the second trimester of pregnancy. A total of 112 families were provided PND services in the last decade and the presence of an affected fetus was confirmed in 32 families. Post-test genetic counseling enabled the affected families to make an informed decision about the current pregnancy.Entities:
Keywords: chorionic villus sampling; cordocentesis; flow cytometry; maternal contamination; prenatal diagnosis; variants of unknown significance
Year: 2020 PMID: 33365035 PMCID: PMC7750517 DOI: 10.3389/fimmu.2020.612316
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561